These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16330793)

  • 1. Pathogenesis of early lung disease in cystic fibrosis: a window of opportunity to eradicate bacteria.
    Starner TD; McCray PB; ;
    Ann Intern Med; 2005 Dec; 143(11):816-22. PubMed ID: 16330793
    [No Abstract]   [Full Text] [Related]  

  • 2. Update in cystic fibrosis 2011.
    Ratjen F; McColley SA
    Am J Respir Crit Care Med; 2012 May; 185(9):933-6. PubMed ID: 22550209
    [No Abstract]   [Full Text] [Related]  

  • 3. Approach to resistant gram-negative bacterial pulmonary infections in patients with cystic fibrosis.
    Chernish RN; Aaron SD
    Curr Opin Pulm Med; 2003 Nov; 9(6):509-15. PubMed ID: 14534404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lower airway microbiota in early cystic fibrosis lung disease: a longitudinal analysis.
    Frayman KB; Armstrong DS; Carzino R; Ferkol TW; Grimwood K; Storch GA; Teo SM; Wylie KM; Ranganathan SC
    Thorax; 2017 Dec; 72(12):1104-1112. PubMed ID: 28280235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive pneumonia and septic shock in infants as a presentation of cystic fibrosis with vitamin-deficiency.
    Al-Khadra ES; Chau KW; Barone CP; Colin AA
    Pediatr Pulmonol; 2012 Jul; 47(7):722-6. PubMed ID: 22684986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Semper aliquod novi cystic fibrosis adferre'. Cystic fibrosis always brings us something new--with apologies to Pliny the Elder.
    Bush A
    Respiration; 2000; 67(3):251-2. PubMed ID: 10979834
    [No Abstract]   [Full Text] [Related]  

  • 7. Cystic fibrosis frequently asked questions.
    Lim SZ; Fitzgerald DA
    Paediatr Respir Rev; 2015 Mar; 16(2):110-1. PubMed ID: 25973462
    [No Abstract]   [Full Text] [Related]  

  • 8. The importance of early diagnosis of Mycobacterium abscessus complex in patients with cystic fibrosis.
    Ravnholt C; Kolpen M; Skov M; Moser C; Katzenstein TL; Pressler T; Høiby N; Qvist T
    APMIS; 2018 Dec; 126(12):885-891. PubMed ID: 30456869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials.
    Bilton D; Canny G; Conway S; Dumcius S; Hjelte L; Proesmans M; Tümmler B; Vavrova V; De Boeck K
    J Cyst Fibros; 2011 Jun; 10 Suppl 2():S79-81. PubMed ID: 21658647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Physiopathology of cystic fibrosis and of infections associated to this disease].
    Aramă SS; Aramă V; Cercel AS; Ion DA; Hristea A; Sotcan M
    Pneumologia; 2007; 56(4):202-7. PubMed ID: 18320796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis: A hereditary disease challenges microbiologists to a duel.
    Heesemann J
    Int J Med Microbiol; 2010 Dec; 300(8):513. PubMed ID: 20940107
    [No Abstract]   [Full Text] [Related]  

  • 12. Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified?
    Macdonald D; Cuthbertson L; Doherty C; Campana S; Ravenni N; Taccetti G; Govan JR
    J Antimicrob Chemother; 2010 Nov; 65(11):2373-5. PubMed ID: 20837573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of cepacia syndrome with a combination of intravenous cyclosporin, antibiotics and oral corticosteroids.
    Gilchrist FJ; Webb AK; Bright-Thomas RJ; Jones AM
    J Cyst Fibros; 2012 Sep; 11(5):458-60. PubMed ID: 22551926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nocardia farcinica infection in a patient with cystic fibrosis].
    Beucher J; Belleguic C; Brinchault G; Deneuville E; Donnio PY; Roussey M
    Rev Mal Respir; 2010; 27(1):76-9. PubMed ID: 20146956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial approaches to therapy for pneumonia.
    Mandell LA
    Curr Opin Pulm Med; 1996 May; 2(3):218-27. PubMed ID: 9363143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of changes in diversity and abundance of the microbial community in a cystic fibrosis patient over a multiyear period.
    Stokell JR; Gharaibeh RZ; Hamp TJ; Zapata MJ; Fodor AA; Steck TR
    J Clin Microbiol; 2015 Jan; 53(1):237-47. PubMed ID: 25392361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of lung infection in patients with cystic fibrosis: current and future strategies.
    Döring G; Flume P; Heijerman H; Elborn JS;
    J Cyst Fibros; 2012 Dec; 11(6):461-79. PubMed ID: 23137712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A French multicentric study and review of pulmonary Nocardia spp. in cystic fibrosis patients.
    Rodriguez-Nava V; Durupt S; Chyderiotis S; Freydière AM; Karsenty J; de Montclos M; Reix P; Durieu I; Nove-Josserand R; Chiron R; Bremont F; Têtu L; Murris M; Terru D; Godreuil S; Bergeron E; Freney J; Boiron P; Vandenesch F; Marchandin H; Segonds C; Doléans-Jordheim A
    Med Microbiol Immunol; 2015 Aug; 204(4):493-504. PubMed ID: 25344657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis.
    Floto RA; Olivier KN; Saiman L; Daley CL; Herrmann JL; Nick JA; Noone PG; Bilton D; Corris P; Gibson RL; Hempstead SE; Koetz K; Sabadosa KA; Sermet-Gaudelus I; Smyth AR; van Ingen J; Wallace RJ; Winthrop KL; Marshall BC; Haworth CS;
    Thorax; 2016 Jan; 71 Suppl 1(Suppl 1):i1-22. PubMed ID: 26666259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A liposome model to treat pseudomonas in lungs of cystic fibrosis and immune compromised patients.
    Yatvin MB
    Cell Mol Biol Lett; 2002; 7(2):304. PubMed ID: 12097974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.